Articles Posted in Transvaginal Mesh Injury

Urologists and specialists from across the nation gathered recently in Orlando to attend the annual American Urological Association (AUA) conference and to debate the use of transvaginal mesh devices.

The AUA has maintained that the used of mid-urethral mesh slings is an important option for women who choose surgical options to treat stress urinary incontinence (SUI). Four specialists debated the safety of the procedure and the severe complications that women are experiencing as a result of the surgeries. Those complications can include erosion of the mesh, chronic pelvic pain and pain during sexual intercourse.

Two of the doctors who support the surgeries said that the benefits far outweigh the complications that women may experience. They argued that the surgeries are minimally invasive and can be done in as little as 22 minutes.

Two specialists, who opposed the surgeries as they are now performed, highlighted the complications caused by procedures. Both doctors said that women have approached them to have the mesh removed.
Continue reading

The Corporate Action Network has launched a campaign to warn women about the risks of transvaginal mesh surgery. The campaign also calls for a formal investigation into Johnson & Johnson’s corporate practices concerning its Ethicon unit, which was responsible for the manufacture and marketing of the corporate giant’s mesh products.

The corporate watchdog group claims that J&J and its top executives acted recklessly in the manufacture and marketing of the company’s mesh products and as a result, thousands of women across the United States have been seriously injured.

The group has launched a website,, that promises to reveal new information about J&J’s corporate abuses towards women. The website urges those with new information concerning J&J’s inappropriate actions to report them on the site. It promises to roll out new information on J&J’s corporate practices on April 26 (complete with ongoing countdown of the hours, minutes and seconds before the reveal).
Continue reading

A U.S. District Judge in West Virginia declared a mistrial in a CR Bard Inc. vaginal-mesh product liability case because a witness’s testimony broached a subject that the judge had ruled could not be divulged during the trial.

Florida Product Liability MistrialThe mistrial was called after a Tampa, Florida gynecological expert mentioned that Bard had withdrawn their vaginal mesh product last year. The federal judge had ruled that the plaintiffs could not mention the company had withdrawn the devices.

The federal judge called the mistrial because he believed the jury would not be able to disregard what it had heard during the expert’s testimony.

This setback comes on the heels of information that Bard used a resin-based plastic in its mesh devices that the manufacturer, Chevron Phillips Chemical Co., expressly said should not be used for human implants. Lawyers for the plaintiffs injured by the vaginal mesh devices allege that an executive at Bard’s Davol Unit, the subsidiary responsible for the vaginal mesh products, went so far as to urge that others in the company to cover-up that Davol was using the Chevron Phillips plastic for medical applications.
Continue reading

The vaginal mesh injury attorneys at Farah & Farah in Jacksonville have learned that Endo Health Solutions has agreed to pay $54.5 million to settle an undetermined number of the some 5,000 pending vaginal mesh injury lawsuits filed against American Medical Systems (AMS).

The vaginal mesh products were manufactured by American Medical Systems (AMS), which was bought by Endo for $2.9 billion in 2011. According to Fierce Medical Devices, problems with the vaginal mesh implants began surfacing some three years before Endo bought AMS. Patients began complaining of pain, organ damage and incontinence allegedly linked to the implanted mesh devices.

Thousand of lawsuits were consolidated and the first AMS vaginal mesh product case was slated to go to trial in a West Virginia federal court in December. According to Bloomberg News, the settlement only resolves a small group of plaintiff’s claims and does not affect a majority of the some 5,000 vaginal-mesh suits filed against AMS.

Although an Endo spokesman refused to comment on the settlement, AMS officials said in a U.S. Security and Exchange Commission (SEC) filing that the company intends “to vigorously defend itself in the remaining mesh liability cases and in any new cases that may arise.”
Continue reading

A study recently published in the Journal of the American Medical Association (JAMA) has found that about one out of every ten women who received a vaginal mesh implant suffered from mesh erosion and movement that could lead to painful and long-lasting complications.

The study looked at two kinds of pelvic organ prolapse surgery techniques and found that some 25 percent of women had recurring symptoms over time and that more than 60 percent developed urinary incontinence, sometimes as a result of the surgery.

Pelvic organ prolapse happens when the uterus or vaginal walls drop after childbirth. This drop can cause pain, incontinence and discomfort. According to experts, most women who have been through childbirth have some degree of prolapse. Some 225,000 women have surgery to relieve symptoms of pelvic organ prolapse every year.

The study, conducted by the Utah University School of Medicine, looked at surgeries involving synthetic mesh used in two different procedures: one where the mesh was inserted through the vagina and the other where the mesh was inserted through the abdomen.
Continue reading

A New Jersey Superior Court Judge presiding over pelvic mesh litigation against Johnson & Johnson and its subsidiary Ethicon, Inc., has ordered three of the company’s top executives to testify in depositions. The judge also ruled that searches of the executive’s computers should be conducted before any depositions are conducted.

Defense attorneys for Johnson & Johnson sought to block the depositions on the grounds that the executives were too high up in the food chain, and therefore would have little relevant knowledge of the process that went into the approval of the vaginal mesh devices. An attorney for the plaintiffs said he was able to show the judge that the executives were involved and therefore their testimony should be part of the ongoing litigation process.

Although the former Chief Executive of J&J was not ordered to testify, the judge left that door open, saying that if any relevant documents were found on his computer then he would also be compelled to give a deposition. So far, the current J&J CEO, the former J&J Vice Chairman, and the Ethicon franchise leader have been told they must testify.
Continue reading